Does ARGININE\LYSINE Cause Malignant neoplasm progression? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Malignant neoplasm progression have been filed in association with ARGININE\LYSINE. This represents 20.9% of all adverse event reports for ARGININE\LYSINE.
33
Reports of Malignant neoplasm progression with ARGININE\LYSINE
20.9%
of all ARGININE\LYSINE reports
21
Deaths
16
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ARGININE\LYSINE?
Of the 33 reports, 21 (63.6%) resulted in death, 16 (48.5%) required hospitalization, and 3 (9.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARGININE\LYSINE. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does ARGININE\LYSINE Cause?
Platelet count decreased (39)
Anaemia (28)
Lymphocyte count decreased (20)
Inappropriate schedule of product administration (18)
White blood cell count decreased (16)
Nausea (15)
Decreased appetite (13)
Diarrhoea (12)
Myelosuppression (12)
Blood pressure systolic increased (11)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ARGININE\LYSINE Alternatives Have Lower Malignant neoplasm progression Risk?
ARGININE\LYSINE vs ARIMIDEX
ARGININE\LYSINE vs ARIPIPRAZOLE
ARGININE\LYSINE vs ARIPIPRAZOLE LAUROXIL
ARGININE\LYSINE vs ARIXTRA
ARGININE\LYSINE vs ARMODAFINIL